Pluripotent stem cells and tolerance induction in organ transplantation

Barbara Imberti, Manuela Monti, Federica Casiraghi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Ongoing research is constantly looking for means to modulate the immune system for long-lasting engraftment of pluripotent stem cells (PSC) during stem cell-based therapies. This study reviews data on in-vitro and in-vivo immunogenicity of embryonic and induced-PSC and describes how their immunological properties can be harnessed for tolerance induction in organ transplantation. RECENT FINDINGS: Although PSC display immunomodulatory properties in vitro, they are capable of eliciting an immune response that leads to cell rejection when transplanted into immune-competent recipients. Nevertheless, long-term acceptance of PSC-derived cells/tissues in an allogeneic environment can be achieved using minimal host conditioning. Protocols for differentiating PSC towards haematopoietic stem cells, thymic epithelial precursors, dendritic cells, regulatory T cells and myeloid-derived suppressor cells are being developed, suggesting the possibility to use PSC-derived immunomodulatory cells to induce tolerance to a solid organ transplant. SUMMARY: PSC and/or their derivatives possess unique immunological properties that allow for acceptance of PSC-derived tissue with minimal host conditioning. Investigators involved either in regenerative or in transplant medicine must join their efforts with the ultimate aim of using PSC as a source of donor-specific cells that would create a protolerogenic environment to achieve tolerance in solid organ transplantation.

Original languageEnglish
Pages (from-to)86-93
Number of pages8
JournalCurrent Opinion in Organ Transplantation
Volume20
Issue number1
DOIs
Publication statusPublished - Feb 21 2015

Fingerprint

Pluripotent Stem Cells
Organ Transplantation
Transplants
Induced Pluripotent Stem Cells
Regulatory T-Lymphocytes
Cell- and Tissue-Based Therapy
Hematopoietic Stem Cells
Dendritic Cells
Immune System
Stem Cells
Research Personnel
Medicine

Keywords

  • embryonic stem cells
  • immunogenicity
  • immunomodulation
  • induced-pluripotent stem cells
  • tolerance induction

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Medicine(all)

Cite this

Pluripotent stem cells and tolerance induction in organ transplantation. / Imberti, Barbara; Monti, Manuela; Casiraghi, Federica.

In: Current Opinion in Organ Transplantation, Vol. 20, No. 1, 21.02.2015, p. 86-93.

Research output: Contribution to journalArticle

@article{eae03abd75c248cdb3884e21eb5af584,
title = "Pluripotent stem cells and tolerance induction in organ transplantation",
abstract = "PURPOSE OF REVIEW: Ongoing research is constantly looking for means to modulate the immune system for long-lasting engraftment of pluripotent stem cells (PSC) during stem cell-based therapies. This study reviews data on in-vitro and in-vivo immunogenicity of embryonic and induced-PSC and describes how their immunological properties can be harnessed for tolerance induction in organ transplantation. RECENT FINDINGS: Although PSC display immunomodulatory properties in vitro, they are capable of eliciting an immune response that leads to cell rejection when transplanted into immune-competent recipients. Nevertheless, long-term acceptance of PSC-derived cells/tissues in an allogeneic environment can be achieved using minimal host conditioning. Protocols for differentiating PSC towards haematopoietic stem cells, thymic epithelial precursors, dendritic cells, regulatory T cells and myeloid-derived suppressor cells are being developed, suggesting the possibility to use PSC-derived immunomodulatory cells to induce tolerance to a solid organ transplant. SUMMARY: PSC and/or their derivatives possess unique immunological properties that allow for acceptance of PSC-derived tissue with minimal host conditioning. Investigators involved either in regenerative or in transplant medicine must join their efforts with the ultimate aim of using PSC as a source of donor-specific cells that would create a protolerogenic environment to achieve tolerance in solid organ transplantation.",
keywords = "embryonic stem cells, immunogenicity, immunomodulation, induced-pluripotent stem cells, tolerance induction",
author = "Barbara Imberti and Manuela Monti and Federica Casiraghi",
year = "2015",
month = "2",
day = "21",
doi = "10.1097/MOT.0000000000000144",
language = "English",
volume = "20",
pages = "86--93",
journal = "Current Opinion in Organ Transplantation",
issn = "1087-2418",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Pluripotent stem cells and tolerance induction in organ transplantation

AU - Imberti, Barbara

AU - Monti, Manuela

AU - Casiraghi, Federica

PY - 2015/2/21

Y1 - 2015/2/21

N2 - PURPOSE OF REVIEW: Ongoing research is constantly looking for means to modulate the immune system for long-lasting engraftment of pluripotent stem cells (PSC) during stem cell-based therapies. This study reviews data on in-vitro and in-vivo immunogenicity of embryonic and induced-PSC and describes how their immunological properties can be harnessed for tolerance induction in organ transplantation. RECENT FINDINGS: Although PSC display immunomodulatory properties in vitro, they are capable of eliciting an immune response that leads to cell rejection when transplanted into immune-competent recipients. Nevertheless, long-term acceptance of PSC-derived cells/tissues in an allogeneic environment can be achieved using minimal host conditioning. Protocols for differentiating PSC towards haematopoietic stem cells, thymic epithelial precursors, dendritic cells, regulatory T cells and myeloid-derived suppressor cells are being developed, suggesting the possibility to use PSC-derived immunomodulatory cells to induce tolerance to a solid organ transplant. SUMMARY: PSC and/or their derivatives possess unique immunological properties that allow for acceptance of PSC-derived tissue with minimal host conditioning. Investigators involved either in regenerative or in transplant medicine must join their efforts with the ultimate aim of using PSC as a source of donor-specific cells that would create a protolerogenic environment to achieve tolerance in solid organ transplantation.

AB - PURPOSE OF REVIEW: Ongoing research is constantly looking for means to modulate the immune system for long-lasting engraftment of pluripotent stem cells (PSC) during stem cell-based therapies. This study reviews data on in-vitro and in-vivo immunogenicity of embryonic and induced-PSC and describes how their immunological properties can be harnessed for tolerance induction in organ transplantation. RECENT FINDINGS: Although PSC display immunomodulatory properties in vitro, they are capable of eliciting an immune response that leads to cell rejection when transplanted into immune-competent recipients. Nevertheless, long-term acceptance of PSC-derived cells/tissues in an allogeneic environment can be achieved using minimal host conditioning. Protocols for differentiating PSC towards haematopoietic stem cells, thymic epithelial precursors, dendritic cells, regulatory T cells and myeloid-derived suppressor cells are being developed, suggesting the possibility to use PSC-derived immunomodulatory cells to induce tolerance to a solid organ transplant. SUMMARY: PSC and/or their derivatives possess unique immunological properties that allow for acceptance of PSC-derived tissue with minimal host conditioning. Investigators involved either in regenerative or in transplant medicine must join their efforts with the ultimate aim of using PSC as a source of donor-specific cells that would create a protolerogenic environment to achieve tolerance in solid organ transplantation.

KW - embryonic stem cells

KW - immunogenicity

KW - immunomodulation

KW - induced-pluripotent stem cells

KW - tolerance induction

UR - http://www.scopus.com/inward/record.url?scp=84921437698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921437698&partnerID=8YFLogxK

U2 - 10.1097/MOT.0000000000000144

DO - 10.1097/MOT.0000000000000144

M3 - Article

C2 - 25522138

AN - SCOPUS:84921437698

VL - 20

SP - 86

EP - 93

JO - Current Opinion in Organ Transplantation

JF - Current Opinion in Organ Transplantation

SN - 1087-2418

IS - 1

ER -